University of Bonn

Tuya Smart Shares Front-line Insights to Advance Discussions on Cyber Norms in Europe

Retrieved on: 
Thursday, March 21, 2024
Comprehension, Certification, Organization, TrustArc, Internet of things, Partnership, International, White paper, GDPR, Tuya, CCPA, Research institute, Leiden University, AWS, Senior, NIST, Amazon Web Services, Computer security, Security studies, HKEX, Legislation, Security, University of Bonn, Medical device

THE HAGUE, Netherlands, March 21, 2024 /PRNewswire/ -- Tuya Smart (NYSE: TUYA, HKEX: 2391), a global IoT developer service provider, shared front-line insights at a cyber norms forum co-hosted by the Research Center for Global Cyberspace Governance (RCGCG) and the Cyber Security Governance of Leiden University to further advance discussions on cybersecurity regulation in Europe.

Key Points: 
  • THE HAGUE, Netherlands, March 21, 2024 /PRNewswire/ -- Tuya Smart (NYSE: TUYA, HKEX: 2391), a global IoT developer service provider, shared front-line insights at a cyber norms forum co-hosted by the Research Center for Global Cyberspace Governance (RCGCG) and the Cyber Security Governance of Leiden University to further advance discussions on cybersecurity regulation in Europe.
  • "Overcoming these challenges demands a comprehensive strategy, incorporating national governance, innovative enterprise-level solutions, and global cooperation," said Holmes Chen, Senior PR Director of Tuya Smart.
  • On the global stage, Tuya has demonstrated its cybersecurity and data protection prowess through the Ernst & Young SOC 2 Audit program.
  • Discussions at the forum also touched on the latest advancements in European legislation, discussing the EU Cybersecurity Act and the European Cyber Resilience Act.

IFCO delivers record environmental savings during 2023 and awards its customers with annual Sustainability Certificates

Retrieved on: 
Tuesday, February 13, 2024
ISO, LCI, Fraunhofer Society, Circular economy, Investment, Biophysical environment, Reusability, Municipal solid waste, ESG, Life-cycle assessment, Climate change, Carbon, Global warming potential, University, Covenant Baptist Theological Seminary, LCIA, University of Bonn, Science, LCA, Container, IPCC, GHG, Water, Recycling

IFCO Sustainability Certificates acknowledge each customer's specific environmental savings achieved together with IFCO in 2023.

Key Points: 
  • IFCO Sustainability Certificates acknowledge each customer's specific environmental savings achieved together with IFCO in 2023.
  • In total, by using the IFCO SmartCycle circular business model, customers have generated the following environmental savings in 2023.
  • Backed by the results of third-party, peer-reviewed Life Cycle Assessment studies, IFCO reliably calculates the environmental benefits of using IFCO RPCs and awards trustworthy Sustainability Certificates to its customers each year.
  • Increasingly, IFCO customers underline the positive impact of using IFCO RPCs in their supply chains by including these environmental savings in their ESG reports and sharing it with their employees, customers and other stakeholders.

IFCO delivers record environmental savings during 2023 and awards its customers with annual Sustainability Certificates

Retrieved on: 
Tuesday, February 13, 2024
ISO, LCI, Fraunhofer Society, Circular economy, Investment, Biophysical environment, Reusability, Municipal solid waste, ESG, Life-cycle assessment, Climate change, Carbon, Global warming potential, University, Covenant Baptist Theological Seminary, LCIA, University of Bonn, Science, LCA, Container, IPCC, GHG, Water, Recycling

IFCO Sustainability Certificates acknowledge each customer's specific environmental savings achieved together with IFCO in 2023.

Key Points: 
  • IFCO Sustainability Certificates acknowledge each customer's specific environmental savings achieved together with IFCO in 2023.
  • In total, by using the IFCO SmartCycle circular business model, customers have generated the following environmental savings in 2023.
  • Backed by the results of third-party, peer-reviewed Life Cycle Assessment studies, IFCO reliably calculates the environmental benefits of using IFCO RPCs and awards trustworthy Sustainability Certificates to its customers each year.
  • Increasingly, IFCO customers underline the positive impact of using IFCO RPCs in their supply chains by including these environmental savings in their ESG reports and sharing it with their employees, customers and other stakeholders.

Nektar Therapeutics Announces Two Abstracts Accepted at EADV Congress 2023 for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy

Retrieved on: 
Monday, October 2, 2023
Nektar, Medical school, Naval Medical Research Center, University, Senior, NKTR, Safety, Efficacy, University School, Nektar Therapeutics, MT, Atopic dermatitis, Washington University School of Medicine, Alopecia areata, University of Washington School of Medicine, Development, Journal of the European Academy of Dermatology and Venereology, Duke University School of Medicine, Patient, SAN, Randomness, Conjugation, University of Rochester Medical Center, Science, University of Bonn, Therapy, Abstract, Queen's University, Treatment, Education, Pharmaceutical industry, Vaccine, PLLC, Dermatology, Regulatory T cell, Venereology, Northwestern University, Medicine

SAN FRANCISCO, Oct. 2, 2023 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) announced today that it will have two presentations for rezpegaldesleukin (REZPEG), a first-in-class selective regulatory T-cell (Treg) therapy, at the 2023 European Academy of Dermatology and Venereology (EADV) Congress to be held October 11-14 in Berlin. REZPEG is in Phase 2 development for the treatment of atopic dermatitis and for the treatment of alopecia areata.

Key Points: 
  • SAN FRANCISCO, Oct. 2, 2023 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) announced today that it will have two presentations for rezpegaldesleukin (REZPEG), a first-in-class selective regulatory T-cell (Treg) therapy, at the 2023 European Academy of Dermatology and Venereology (EADV) Congress to be held October 11-14 in Berlin.
  • REZPEG is in Phase 2 development for the treatment of atopic dermatitis and for the treatment of alopecia areata.
  • "The presentations highlight the momentum and strength of our REZPEG program and, in particular, its potential as a remittive therapy for patients with atopic dermatitis.
  • Sinai, New York, NY, United States; 6Skin Sciences, PLLC, Louisville, KY, United States; 7Rodgers Dermatology, Frisco, TX, United States; 8Nektar Therapeutics, San Francisco, CA, United States; 9Eli Lilly and Company, Indianapolis, IN, United States.

CordenPharma Establishes World-Class Technology & Science Advisory Board of Experts Across Six Technology Platforms

Retrieved on: 
Wednesday, July 26, 2023
Biochemistry, Business development, Drug development, University, Drug delivery, Organic chemistry, Approved Drug Products with Therapeutic Equivalence Evaluations, Institute of technology, Biotechnology, Lipid, MBA, OSD, Technical University of Berlin, RNA, University of Bonn, University of Graz, CDMO, Professor, Machine learning, Pharmaceutics, Knowledge, Growth, AI, API, LNP, Solid lipid nanoparticle, Oligonucleotide, Bipolar Integrated Technology, Pharmacology, Peptide, Fine chemical, Vaccine, Management, Biopharmaceutical, Chemistry, Ludwig Maximilian University of Munich

CDMO CordenPharma establishes world-class Technology & Science Advisory Board of experts across 6 technology platforms.

Key Points: 
  • CDMO CordenPharma establishes world-class Technology & Science Advisory Board of experts across 6 technology platforms.
  • The formation of the Technology & Science Advisory Board was born out of CordenPharma's commitment to stay at the forefront of the pharmaceutical and biotechnology industries.
  • Their collective expertise will provide valuable insights into emerging trends, cutting-edge technologies, and regulatory advancements across all six CordenPharma technology platforms .
  • Dr. Michael Quirmbach, CEO & President at CordenPharma, said: "CordenPharma is honored to have the opportunity to work with these distinguished scientific experts.

CordenPharma Establishes World-Class Technology & Science Advisory Board of Experts Across Six Technology Platforms

Retrieved on: 
Wednesday, July 26, 2023
Biochemistry, Business development, Drug development, University, Drug delivery, Organic chemistry, Approved Drug Products with Therapeutic Equivalence Evaluations, Institute of technology, Biotechnology, Lipid, MBA, OSD, Technical University of Berlin, RNA, University of Bonn, University of Graz, CDMO, Professor, Machine learning, Pharmaceutics, Knowledge, Growth, AI, API, LNP, Solid lipid nanoparticle, Oligonucleotide, Bipolar Integrated Technology, Pharmacology, Peptide, Fine chemical, Management, Biopharmaceutical, Chemistry, Ludwig Maximilian University of Munich

The formation of the Technology & Science Advisory Board was born out of CordenPharma's commitment to stay at the forefront of the pharmaceutical and biotechnology industries.

Key Points: 
  • The formation of the Technology & Science Advisory Board was born out of CordenPharma's commitment to stay at the forefront of the pharmaceutical and biotechnology industries.
  • CordenPharma's TSAB brings together eight scientific experts from various disciplines, including chemistry, pharmacology, biotechnology, and regulatory affairs.
  • Their collective expertise will provide valuable insights into emerging trends, cutting-edge technologies, and regulatory advancements across all six CordenPharma technology platforms .
  • Dr. Michael Quirmbach, CEO & President at CordenPharma, said: "CordenPharma is honored to have the opportunity to work with these distinguished scientific experts.

Alamar Biosciences Unveils Novel Proteomics Platform with Best-in-Class Sensitivity and High Multiplexing Capability

Retrieved on: 
Wednesday, April 12, 2023
Innate immune system, University, Protein, Therapy, BioRxiv, Workflow, NGS, Liquid biopsy, Immunoassay, Proteome, Medicine, Biomarker, Inflammation, Doctor of Philosophy, Proteomics, MD, Plasma, Blood, Massive parallel sequencing, University of Bonn, Interferon, Disease, Vaccine, Medical imaging

FREMONT, Calif., April 12, 2023 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced today the unveiling of its technology platform NULISA™, a novel automated ultrasensitive and highly multiplexed proteomics technology for liquid biopsy.

Key Points: 
  • FREMONT, Calif., April 12, 2023 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced today the unveiling of its technology platform NULISA™, a novel automated ultrasensitive and highly multiplexed proteomics technology for liquid biopsy.
  • The bioRxiv publication, titled NULISA: a novel proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing , provides detailed information on the development and validation of NULISA and showcases its superior sensitivity to existing platforms in real-world applications.
  • "The NULISA platform reinvents the immunoassay by leveraging our proprietary signal-to-noise ratio enhancement technology, along with the latest advancements in Next-Generation Sequencing (NGS), to bring both ultra-high sensitivity and high multiplexing to proteomic analysis," said Dr. Yuling Luo, Founder, Chairman & CEO of Alamar.
  • "NULISA assays will now provide researchers with the ability to profile multiple proteins at once with high sensitivity and reproducibility."

Revance to Present New Data on DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia at the Association of Academic Physiatrists Annual Meeting

Retrieved on: 
Thursday, February 23, 2023
Health, FDA, Other Health, Clinical Trials, Pharmaceutical, Biotechnology, Obsidian, Medical school, Death, Speech, University of California, Therapy, Headache, Patient, MD, University, Hubli railway division, Pregnancy, MBA, New England Institute of Religious Research, Torticollis, OLS, University of Bonn, ASPEN, Rostov State Medical University, Spasticity, Dysphagia, Neurotoxin, Neurology, AAP, Medication, Food, Poster, Physician, Food and Drug Administration Amendments Act of 2007, Pharmaceutical industry, Online shopping

(RVNC) today announced that new data on DAXXIFY ® will be presented at the annual meeting of Association of Academic Physiatrists (AAP), taking place in Anaheim, California, February 21-24, 2023.

Key Points: 
  • (RVNC) today announced that new data on DAXXIFY ® will be presented at the annual meeting of Association of Academic Physiatrists (AAP), taking place in Anaheim, California, February 21-24, 2023.
  • The supplemental biologics license agreement for DAXXIFY® for the treatment of cervical dystonia is currently under regulatory review with the Food and Drug Administration.
  • The findings reinforce the extended duration of efficacy and favorable safety profile of DAXXIFY®.
  • Dysphagia rates (difficulty swallowing) were low (2.7% for ASPEN-1 and 4.2% for ASPEN-OLS), further supporting DAXXIFY’s safety profile.

International Centre for Mathematics in Ukraine to be launched in 2023, enabled by Founding and Principal Donor XTX Markets

Retrieved on: 
Thursday, January 12, 2023
Fields Medal, Economics, University of Chicago, Max Planck Institute for Mathematics in the Sciences, IHES, University, University of Bonn, International Centre for Mathematical Sciences, Coordinating Committee for Earthquake Prediction, Maryna Viazovska, European Mathematical Society, University of California, XTX Markets, Kyiv School of Economics, Knowledge, XTX, Max Planck, Rest, International Centre, Research, University of Central Florida Board of Trustees, Science, Freedom, European, Institute of Mathematics of the Polish Academy of Sciences, Polish Academy of Arts and Sciences, Pharmaceutical industry, Management, Civil engineering, Mathematics, Trustee

To support this, a group of leading Ukrainian mathematicians are founding a new centre for mathematical research, thanks to funding from Founding and Principal Donor XTX Markets.

Key Points: 
  • To support this, a group of leading Ukrainian mathematicians are founding a new centre for mathematical research, thanks to funding from Founding and Principal Donor XTX Markets.
  • The mission of the Centre will be to support top-level research in mathematics, with special emphasis on training younger generations of mathematicians and the development of mathematics in Ukraine.
  • Building on a strong mathematical tradition in Ukraine, the new Centre will be driven by excellence and freedom in research.
  • The support from our Founding and Principal Donor, XTX Markets, is crucial at this foundational stage and we look forward to working with them going forward.''

International Centre for Mathematics in Ukraine to be launched in 2023, enabled by Founding and Principal Donor XTX Markets

Retrieved on: 
Thursday, January 12, 2023
Fields Medal, Economics, University of Chicago, Max Planck Institute for Mathematics in the Sciences, IHES, University, University of Bonn, International Centre for Mathematical Sciences, Coordinating Committee for Earthquake Prediction, Maryna Viazovska, European Mathematical Society, University of California, XTX Markets, Kyiv School of Economics, Knowledge, XTX, Max Planck, Rest, International Centre, Research, University of Central Florida Board of Trustees, Science, Freedom, European, Institute of Mathematics of the Polish Academy of Sciences, Polish Academy of Arts and Sciences, Pharmaceutical industry, Management, Civil engineering, Mathematics, Trustee

To support this, a group of leading Ukrainian mathematicians are founding a new centre for mathematical research, thanks to funding from Founding and Principal Donor XTX Markets.

Key Points: 
  • To support this, a group of leading Ukrainian mathematicians are founding a new centre for mathematical research, thanks to funding from Founding and Principal Donor XTX Markets.
  • The mission of the Centre will be to support top-level research in mathematics, with special emphasis on training younger generations of mathematicians and the development of mathematics in Ukraine.
  • Building on a strong mathematical tradition in Ukraine, the new Centre will be driven by excellence and freedom in research.
  • The support from our Founding and Principal Donor, XTX Markets, is crucial at this foundational stage and we look forward to working with them going forward.''